Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125636352 | 12563635 | 2 | F | 20160301 | 20160712 | 20160715 | 20160722 | EXP | US-ASTRAZENECA-2016SE76838 | ASTRAZENECA | 72.00 | YR | M | Y | 0.00000 | 20160722 | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125636352 | 12563635 | 1 | PS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | UNK, TWO TIMES A DAY | U | U | 0 | TABLET | |||||||
| 125636352 | 12563635 | 2 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125636352 | 12563635 | 3 | SS | UROREC | SILODOSIN | 1 | Unknown | 0.8MG UNKNOWN | U | U | 0 | .8 | MG | ||||||
| 125636352 | 12563635 | 4 | SS | APIDRA | INSULIN GLULISINE | 1 | Subcutaneous | UNK | U | U | 5S372A | 0 | |||||||
| 125636352 | 12563635 | 5 | SS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 6.0IU UNKNOWN | U | 0 | 6 | IU | |||||||
| 125636352 | 12563635 | 6 | SS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 3.0IU UNKNOWN | U | 0 | 3 | IU | |||||||
| 125636352 | 12563635 | 7 | SS | MADOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125636352 | 12563635 | 8 | SS | AVODART | DUTASTERIDE | 1 | Unknown | U | U | 0 | .5 | MG | QD | ||||||
| 125636352 | 12563635 | 9 | SS | NEUPRO | ROTIGOTINE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125636352 | 12563635 | 1 | Product used for unknown indication |
| 125636352 | 12563635 | 2 | Product used for unknown indication |
| 125636352 | 12563635 | 3 | Product used for unknown indication |
| 125636352 | 12563635 | 4 | Diabetes mellitus |
| 125636352 | 12563635 | 5 | Diabetes mellitus |
| 125636352 | 12563635 | 6 | Diabetes mellitus |
| 125636352 | 12563635 | 7 | Product used for unknown indication |
| 125636352 | 12563635 | 8 | Product used for unknown indication |
| 125636352 | 12563635 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125636352 | 12563635 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125636352 | 12563635 | Capillary fragility | |
| 125636352 | 12563635 | Hyperglycaemia | |
| 125636352 | 12563635 | Hypoglycaemia | |
| 125636352 | 12563635 | Joint swelling | |
| 125636352 | 12563635 | Nausea | |
| 125636352 | 12563635 | Paraesthesia | |
| 125636352 | 12563635 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |